Capsid Restructuring Activates Semi-Conservative dsRNA Transcription in Cystovirus ɸ6.
Ilca SL. et al, (2025), bioRxiv
Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.
Zhang Y. et al, (2025), NPJ Vaccines, 10
An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.
Zhang Y. et al, (2025), NPJ Vaccines, 10
Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories.
Zwerwer LR. et al, (2025), Nat Commun, 16
Production of an immunogenic trivalent poliovirus virus-like particle vaccine candidate in yeast using controlled fermentation.
Sherry L. et al, (2025), NPJ Vaccines, 10
TomoCPT: a generalizable model for 3D particle detection and localization in cryo-electron tomograms.
Shah PNM. et al, (2025), Acta Crystallogr D Struct Biol, 81, 63 - 76
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines.
Sherry L. et al, (2025), Nat Commun, 16
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Callaby H. et al, (2025), Lancet Infect Dis, 25, e4 - e5
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure, 32, 1594 - 1602.e6
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam.
Thanh TT. et al, (2024), Int J Infect Dis, 147
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
Asor R. et al, (2024), Proc Natl Acad Sci U S A, 121
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies.
Clarke JD. et al, (2024), Acta Crystallogr F Struct Biol Commun, 80, 154 - 163
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.
Pouwels KB. et al, (2024), Nat Commun, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med, 5
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nat Commun, 15
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2024), Nat Commun, 15
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D. et al, (2024), Nat Commun, 15